Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorota Stary

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Aging Neuroscience|December 23, 2022
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeuticsZofia Chrienova, David Rysanek, Patrik Oleksak, et al.
Bioorganic Chemistry|July 4, 2021
Cyanobiphenyls: Novel H<sub>3</sub> receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's diseaseJustyna Godyń, Paula Zaręba, Dorota Łażewska, et al.
European Journal of Medicinal Chemistry|September 4, 2020
Rational design of new multitarget histamine H<sub>3</sub> receptor ligands as potential candidates for treatment of Alzheimer's diseaseDorota Łażewska, Marek Bajda, Maria Kaleta, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Benzophenone Derivatives with Histamine H<sub>3</sub> Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's DiseaseJustyna Godyń, Paula Zaręba, Dorota Stary, et al.
Cancer Cell International|May 7, 2026
In silico screening, synthesis, and biological evaluation of pyrazolopyrimidine-derived mTOR inhibitors for anticancer and senomorphic effectsDavid Rysanek, Zofia Chrienova, Dorota Stary, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Aging Neuroscience|December 23, 2022
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeuticsZofia Chrienova, David Rysanek, Patrik Oleksak, et al.
Bioorganic Chemistry|July 4, 2021
Cyanobiphenyls: Novel H<sub>3</sub> receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's diseaseJustyna Godyń, Paula Zaręba, Dorota Łażewska, et al.
European Journal of Medicinal Chemistry|September 4, 2020
Rational design of new multitarget histamine H<sub>3</sub> receptor ligands as potential candidates for treatment of Alzheimer's diseaseDorota Łażewska, Marek Bajda, Maria Kaleta, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Benzophenone Derivatives with Histamine H<sub>3</sub> Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's DiseaseJustyna Godyń, Paula Zaręba, Dorota Stary, et al.
Cancer Cell International|May 7, 2026
In silico screening, synthesis, and biological evaluation of pyrazolopyrimidine-derived mTOR inhibitors for anticancer and senomorphic effectsDavid Rysanek, Zofia Chrienova, Dorota Stary, et al.
Pageof 2